The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

A new study by researchers at Karolinska Institutet and Karolinska University Hospital shows that patients diagnosed with the ...

B-cell lymphomas, which tend to be nodal based, are the more common type, and only rarely have cutaneous manifestations. In contrast, however, T-cell lymphomas commonly manifest in the skin.

Patients with primary cutaneous B-cell lymphoma showed a higher risk of developing prostate and hematologic cancers in a recent study.

If your doctor tells you that you have B-cell lymphoma, it means you have a cancer that forms in white blood cells called lymphocytes. Find out what causes it, the symptoms, and the reasons you ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and more.

Ciltacabtagene autoleucel (cilta-cel) is an FDA-approved anti–B-cell maturation antigen–directed CAR T-cell therapy that is produced by means of lentiviral transduction.

Although stage 4 diffuse large B-cell lymphoma (DLBCL) is an advanced cancer, it is treatable, and in some cases, remission is possible.

A Swedish study indicates a 21% increase in Lymphoma cases among tattooed individuals, though experts stress this correlation does not imply causation. Despite some carcinogenic chemicals in tattoo ...

Cutaneous B cell lymphoma (CBCL) is an unusual type of lymphoma that starts in the skin. People tend to have lumps on their skin in 1 or 2 areas, rather than affecting all of the body.

Blood cancers, encompassing leukaemia, lymphoma, and myeloma, arise from malfunctions in blood cell production and function.

A year after it was hit with a rejection from the FDA, Citius Pharmaceuticals has scored an approval for Lymphir to treat cutaneous T-Cell Lymphoma.